Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: LABORATORY CORPORATION OF AMERICA
Awarding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Funding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Period of performance: 2021-06-02 to 2022-02-14
Current total value of award: $4192500
Description: ASSESSMENT OF SARS-COV-2 SEROPREVALENCE AND IMMUNE RESPONSES